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Abstract 
Triapine (3-AP), a ribonucleotide reductase inhibitor, has been extensively evaluated in clinical trials in 
the last decade. This study addresses the role of ER stress in the anticancer activity of 3-AP and the 
derivative 3-AP-Me, differing from 3-AP only by dimethylation of the terminal nitrogen. Treatment of 
colon cancer cells with 3-AP or 3-AP-Me activated all three ER stress pathways (PERK, IRE1a and 
ATF6) by phosphorylation of eIF2α and upregulation of ATF4 and ATF6 gene expression, and 
particularly 3-AP-Me lead to an upregulation of the alternatively spliced mRNA variant XBP1s (16-fold). 
Moreover, 3-AP and 3-AP-Me activated the cellular stress kinases JNK and p38 MAPK, and inhibition of 
JNK activity antagonized the cytotoxic effect of both compounds. Subsequent to induction of the 
unfolded protein response (UPR), a significant upregulation of pro-apoptotic proteins was detected, 
including the transcription factor CHOP and the BH3-only member protein Bim, an essential factor for 
ER stress-related apoptosis. In correlation with the higher degree of ER stress after 3-AP-Me treatment, 
also a more potent depolarization of mitochondrial membranes was found. These data suggest that 3-AP 
and 3-AP-Me induce apoptosis via ER stress. This was further corroborated by showing that inhibition of 
protein biosynthesis with cycloheximide prior to 3-AP and 3-AP-Me treatment leads to a significant 
reduction of the anti-proliferative properties of both compounds. Taken together, this study demonstrates 
that induction of ER stress contributes to the mode of action of 3-AP and that terminal methylation leads 
to an even more pronounced manifestation of this effect.  
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Introduction 
Triapine (3-AP; Fig. 1A) belongs to the large class of α-N-heterocyclic thiosemicarbazones. Its antitumor 
activity has been known for more than a decade and was studied in several clinical phase I and phase II 
trials (Nutting et al., 2009; Kunos et al., 2010; Traynor et al., 2010; Ocean et al., 2011). The anticancer 
activity of 3-AP has been attributed to the inhibition of the ribonucleotide reductase enzyme (Finch et al., 
2000). Human ribonucleotide reductase is a tetramer consisting of two large subunits (hRRM1) bearing 
the substrate binding site and two small subunits (hRRM2 or p53R2) containing the catalytically active 
site which harbors a tyrosyl radical stabilized by a di-iron center (Eklund et al., 2001). This enzyme 
catalyzes the reduction of ribonucleotides to deoxyribonucleotides, which are required for DNA synthesis. 
Due to a higher demand for DNA replication and repair in tumor cells, ribonucleotide reductase is a 
suitable and well-established molecular target for cancer therapy. It can be inhibited by radical scavengers 
which interfere with the tyrosyl radical (e.g. hydroxyurea), nucleoside and nucleotide analogues (e.g. 
gemcitabine, cytarabine), and iron chelators (e.g. desferrioxamine) which interact with the iron center of 
the enzyme (Wijerathna et al., 2011). For α-N-heterocyclic thiosemicarbazones such as 3-AP, the 
suggested mode of action is the intracellular formation of very stable iron complexes and subsequent 
generation of reactive oxygen species (ROS) which inhibit ribonucleotide reductase by destruction of the 
tyrosyl radical (Shao et al., 2006). Electron paramagnetic resonance (EPR) spectroscopy measurements of 
3-AP-treated neuroepithelioma cells have demonstrated a decrease of the tyrosyl radical to 61% of the 
control, comparable to the effect of the pyridoxal isonicotinoyl class iron chelator 311; but whereas the 
addition of iron decreased the cytotoxicity of the iron chelators desferrioxamine and 311, iron 
supplementation prior to 3-AP treatment had no significant effects on its cytotoxicity (Chaston et al., 
2003). Furthermore, hydroxyurea-resistant cell lines overexpressing the hRRM2 subunit of ribonucleotide 
reductase showed no resistance to 3-AP (Yen et al., 1994; Finch et al., 1999), and analysis of recombinant 
ribonucleotide reductase by EPR spectroscopy revealed that 3-AP does not significantly remove iron from 
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hRRM2 (Shao et al., 2006). The complexity of these findings indicates that, in addition to ribonucleotide 
reductase inhibition, further mechanisms may contribute to the activity of 3-AP.  
In previous studies, we demonstrated that chemical modification of various thiosemicarbazones by 
dimethylation of the terminal amino group has a strong impact on their biological activity (Kowol et al., 
2009). In the present study, we show that 3-AP and its dimethylated derivative 3-AP-Me particularly 
co-localize with mitochondria and endoplasmic reticulum (ER), which inspired us to further examine the 
impact of the two drugs on the ER. 
One of the functions of the ER is folding of secreted and resident proteins into their native structures and 
the corresponding quality control of newly synthesized proteins (Ellgaard and Helenius, 2003). ER stress 
is induced by the accumulation of misfolded and/or unfolded proteins in the ER lumen, which leads to 
disruption of ER homeostasis. Subsequently, the unfolded protein response (UPR) is initiated by 
dissociation of the ER-resident chaperone glucose-regulated protein 78 kDa (GRP78) from the three ER 
transmembrane proteins PERK, IRE1a, and ATF6 (Szegezdi et al., 2006; Ron and Walter, 2007). This 
cellular response is followed by the upregulation of ER-related chaperones and inhibition of the 
translation machinery to restore correct protein folding and ER homeostasis. However, severe ER stress 
(e.g. initiated by cytotoxic agents) leads to a change in the UPR pathway from pro-survival to pro-
apoptotic signaling (Xu et al., 2005). In this context, the transcription factor CHOP (CCAAT/enhancer-
binding protein homologous protein, also called GADD153) is crucial for switching to pro-apoptotic 
signaling (Oyadomari and Mori, 2004). CHOP is strongly associated with induction of ER stress-
mediated apoptosis by altering the balance between pro-survival and pro-apoptotic bcl-2 family members 
and by stimulating death receptor 5 (DR5) (McCullough et al., 2001; Yamaguchi and Wang, 2004; 
Puthalakath et al., 2007). Due to high metabolic activity and elevated levels of chronic stress in cancer 
cells, targeting the ER stress response is a new promising strategy against cancer (Healy et al., 2009). 
In this study, we demonstrate that treatment of cancer cells with 3-AP (Fig. 1) leads to a pronounced 
expression of proteins associated with ER stress and ER stress-mediated apoptosis and to depolarization 
of mitochondrial membranes. These effects can be observed to an even stronger extent when the 
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dimethylated derivative 3-AP-Me is applied instead of 3-AP. These findings suggest a hitherto 
overlooked role of ER stress as a novel molecular mechanism of α-N-heterocyclic thiosemicarbazones. 
Materials and methods 
Reagents and antibodies. 3-AP and 3-AP-Me were synthesized as reported previously (Kowol et al., 
2009). Both compounds were dissolved in DMSO and then diluted in cell culture medium to obtain the 
indicated concentrations. All cell culture media and solutions were purchased from Sigma-Aldrich 
Austria. Calnexin, Calreticulin, PERK, p-eIF2α,  total eIF2-α, p-p38 MAPK, total p38 MAPK, GRP78, p-
JNK, total JNK, Bim  and β-actin antibodies were purchased from Cell Signaling Technology (Danvers, 
MA). CHOP antibody, cycloheximide (CHX) and JNK inhibitor SP600125 were purchased from Abcam 
(Cambridge, UK). Horseradish peroxidase-labeled anti-mouse IgG and anti-rabbit IgG secondary 
antibodies were purchased from Cell Signaling Technology. Thapsigargin was obtained from Sigma 
Aldrich (Vienna, Austria).  
Cell culture conditions. SW480, HCT-116 (both colon carcinoma, human) and HL-60 cells 
(promyelocytic leukemia, human) were purchased from the American Type Culture Collection (ATCC). 
Cells were grown in Eagle’s Minimal Essential Medium (MEM) supplemented with 10% heat-inactivated 
fetal bovine serum, 1 mM sodium pyruvate, 4 mM L-glutamine, and 1% nonessential amino acids (from 
100x ready-to-use stock solution) in a humidified incubator at 37°C and 5% CO2. For cell culture 
experiments, exponentially grown cells were washed with phosphate buffered saline (PBS) before used in 
the methods described below. 
Fluorescence microscopy. SW480 cells were cultured on cover slips in 6-well plates (Starlab, Hamburg, 
Germany). A flow cell slide was used for stepwise staining of the cell population. Fluorescence 
microscope BX40 with F-View CCD Camera, Cell^F fluorescence imaging software and 60x 
magnification oil immersion objective lens (all from Olympus, Vienna, Austria) were used. Cells were 
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incubated with 100 µM 3-AP and 3-AP-Me in MEM for 5 min and washed three times with PBS before 
image acquisition. ER-Tracker Green and Mito-Tracker Red (Invitrogen, Vienna, Austria) were used 
according to the instructions of the manufacturer. Use of a flow cell microscope slide allowed a stepwise 
staining procedure and prevented bleed-through of fluorochromes.  
Measurement of intracellular oxidants. 2 ,´7´-Dichlorofluorescein diacetate (DCF-DA) was used to 
detect the production of ROS (Gomes et al., 2005). DCF-DA stock solutions (33.4 mM, DMSO) were 
stored at –20 °C. HL60 cells (2.5×105 cells per sample in phenol-free Hanks balanced salt solution) were 
incubated with DCF-DA (1 µM) for 30 min. Subsequently, the compounds were added in the indicated 
concentrations. After incubation for another 30 min, mean fluorescence intensity was measured by flow 
cytometry using a fluorescence-activated cell sorting (FACS) Calibur instrument (Becton Dickinson, 
Schwechat, Austria). A concentration of 200 µM H2O2 was used as positive control. The resulting 
histograms were quantified by using the ModeFit software (BD).  
Western blot analysis. 2.5×105 SW480 cells were seeded 24 h prior to treatment into 6-well plates. Cells 
were exposed to 1, 5, 25 and 50 µM 3-AP or 3-AP-Me for different incubation times. Thapsigargin (0.5 
µM) was used as a positive control. Total cell lysates were prepared by lysis with 
radioimmunoprecipitation assay (RIPA) buffer including protease and phosphatase inhibitor cocktails 
(Sigma-Aldrich). Identical amounts of total proteins were resolved by SDS-PAGE and electrophoretically 
transferred onto a nitrocellulose membrane by using a semi-dry blotter (Peqlab, Erlangen, Germany). The 
membrane was blocked with 5% BSA in TBST buffer for 1 h at room temperature. Primary antibodies 
were diluted according to the instructions of the manufacturer and incubated overnight at 4 °C. Anti-β-
actin was used as a loading control. Secondary antibodies were appropriately diluted and incubated for 
1 h at room temperature. Horseradish peroxidase-coupled secondary antibodies were detected by 
chemiluminescence using Super Signal chemiluminescence substrate from Pierce and chemiluminescence 
detection system Fusion SL (Vilber Lourmat, Eberhardzell, Germany). 
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Cytotoxicity tests in cancer cell lines. Cytotoxic effects of the test compounds together with protein 
synthesis and JNK inhibitors were determined by means of a colorimetric microculture assay [MTT assay, 
MTT = 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide]. Cells grown as adherent 
monolayer in 75 cm2 flasks (Starlabs, Hamburg, Germany) were harvested by trypsinisation. By using a 
pipetting system (Biotek Precision XS Microplate Sample Processor), and densities of 2×103 cells (HCT-
116) were seeded in triplicate 100 µl aliquots into 96-well microculture plates (Starlabs, Hamburg, 
Germany). Before drug exposure, cells were allowed to settle and attach to plates in drug-free complete 
culture medium for 24 h. Test compounds were dissolved in distilled water prior to the preparation of a 
serial dilution in complete culture medium. The dilution series as well as the pipetting steps were done by 
the microplate processor. After 96 h of exposure, the medium was removed and replaced by 100 µl 1:7 
MTT/RPMI-1640 solution (MTT solution: 5 mg/ml MTT in phosphate buffered saline) for 4 h incubation 
at 37 °C in a humidified atmosphere containing 5% CO2. Subsequently, the MTT/RPMI solution was 
removed from all wells and the formazan crystals formed by viable cells were dissolved in 150 µl DMSO 
per well. Optical densities at 550 nm were measured with a microplate reader (Biotek ELx808), by using 
a reference wavelength of 690 nm to correct for unspecific absorption. The quantity of viable cells was 
expressed in terms of the T/C values by a comparison to untreated control microcultures, and 50% 
inhibitory concentrations (IC50) were calculated from concentration-effect curves by interpolation. 
Evaluation is based on means from at least three independent experiments. 
RT-qPCR. Sequences of primers and hydrolysis probes (Supplemental Tables 1;2) were designed with 
Primer Express version 2.0 software (Applied Biosystems, Vienna, Austria). Primers were analyzed for 
all primer secondary structures including hairpins, self-dimers, and cross-dimers in primer pairs using 
NetPrimer software (Premier Biosoft, Palo Alto, CA) and for specificity using Primer-BLAST of NCBI. 
Amplicon secondary structure was assessed with mfold web server (Zuker, 2003). 
Treated and mock-treated SW480 cells were lyzed with QIAzol (Qiagen, Vienna, Austria). For automated 
isolation of total RNA the miRNeasy Kit (Qiagen, Vienna, Austria) was used on the QIAcube robot 
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(Qiagen, Vienna, Austria). RNA amount was measured spectrophotometrically with the BioPhotometer 
6131 combined with the TrayCell cuvette (Eppendorf, Vienna, Austria; Hellma Worldwide, Müllheim, 
Germany). RNA integrity number (RIN) determined with the RNA 6000 Nano Chip Kit (Agilent 
Technologies) on the 2100 Bioanalyzer (Agilent Technologies, Vienna, Austria) was ≥ 7 for experimental 
samples. The High-Capacity Reverse Transcription Kit (Applied Biosystems, Vienna, Austria) was used 
for random hexamer primed cDNA synthesis incubated at 37 °C for 120 min. The 20 µl multiplexed 
qPCR consisted of Rotor Gene Multiplex PCR Kit (Qiagen, Vienna, Austria), 150 nM of each primer, 
150 nM target probe, 150 nM reference gene probe and was performed with 10 ng cDNA triplicates. For 
qPCR conducted on the ViiA7 Real-Time PCR System (Applied Biosystems, Vienna, Austria), a 
temperature protocol with an initial hot start at 95 °C for 5 min followed by 50 amplification cycles (95°C 
for 15 s, 58 °C for 25 s, 60 °C for 25 s) was used. High resolution melting curve analysis was performed 
to ensure specificity. Target expression was normalized by the reference gene TATA box binding protein, 
TBP (Kwon et al., 2009) which displayed minimal variation across experimental groups (∆Cq < 0,84). A 
series of five eight-fold dilutions of a control cDNA from mock-treated SW480 or HCT-116 cells 
amplified in triplicate was used to generate a standard curve. Reaction efficiencies (E) calculated from the 
slope of the standard curve using the formula E = 10-1/slope ranged from 84% to 100% (Supplemental 
Table 2). Calculation of expression changes and evaluation of their statistical significance were performed 
using the Relative Expression Software Tool (REST) 2007 software including the Pair Wise Fixed 
Reallocation Randomisation Test (Pfaffl et al., 2002). Finally, the n-fold expression change of the two 
splicing variants was given relative to the untreated control group. 
Analysis of mitochondrial membrane potential. Depolarization of mitochondrial membrane potential 
was determined by FACS analysis using JC-1 (5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazol-
carbocyanine iodide, Biovision), which forms in intact mitochondria multimer J-aggregates emitting 
fluorescent light at 590 nm. Loss of mitochondrial membrane potential leads to dissociation of J-
aggregates to monomers, which implicates a change in the emission wavelength to 527 nm (Salvioli et al., 
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1997). For this purpose, HL-60 cells were treated with 0.25, 0.5, and 1 µM 3-AP or 3-AP-Me for 24 h. 
After treatment, cells were pelleted, washed with PBS and stained with 2 µg/ml JC-1 for 20 min at 37 °C. 
After staining, cells were washed twice with PBS and analyzed with a Guava 8HT flow cytometer 
(Millipore, Vienna, Austria). Results were repeated in three independent experiments, and statistical 
analysis was performed with FlowJo software. 
Statistical analysis. Error bars represent the standard error of the arithmetic mean (SEM). One-way 
ANOVA were used for statistical analysis using GraphPad Prism Version 5.0 (GraphPad 
Software).Values of P less than 0.05 were considered to represent statistically significant differences. 
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Results 
Co-localization of 3-AP and 3-AP-Me with ER and mitochondria. We found that 3-AP-Me has similar 
intrinsic fluorescence properties in terms of maximum excitation and emission wavelengths as the already 
reported 3-AP (Fig. 1) (Kowol et al., 2010). Intracellular distribution of both compounds was examined in 
SW480 colon carcinoma cells by fluorescence microscopy in a live cell setting (Fig. 2). The cellular 
uptake of both compounds was remarkably quick (within 5 min), and longer incubation times did not 
improve the image quality. Sequential co-staining in a flow chamber with ER-Tracker Green and Mito-
Tracker Red was used to study the co-localization with organelles of both compounds and prevented 
interference of the fluorochromes. Microscopic images (Fig. 2) show a preferred localization of both 
compounds in structures of the cytoplasm. While 3-AP accumulated in more granular structures, which 
match with mitochondria (see zoomed details in Fig. 2A); on the contrary, images of 3-AP-Me show a 
mesh-like structure comparable with the structures observed with ER-Tracker Green. Thus, intracellular 
distribution on the light microscopy scale suggests a direct interaction of both compounds with ER and/or 
mitochondria. 
3-AP and 3-AP-Me induce pro-apoptotic signaling of the unfolded protein response. The comparable 
cytotoxicity of 3-AP and 3-AP-Me is an optimal basis for studying differences in their molecular 
mechanisms of action. Protein levels and mRNA expression of key factors of the UPR were determined to 
assess the influence of 3-AP and 3-AP-Me on ER homeostasis (Fig. 3). As activation of UPR proteins is 
strongly time-dependent, different time points for Western blot analysis were chosen. The ER stress 
inducer thapsigargin was used as a positive control. As shown in Figure 3, a concentration of 1 µM of 3-
AP-Me led to an activation of PERK in HCT-116 cells, whereas only a slight activation of PERK was 
observed in SW480. 3-AP-Me treatment resulted in both cell lines in phosphorylation of eIF-2α, a 
downstream target of PERK and suppressor of the protein translation machinery. In contrast, 3-AP only 
slightly increased eIF-2α phosphorylation at the highest tested concentration (25 µM). Enhanced 
expression of the lectin ER-chaperon Calreticulin after 3-AP-Me treatment was observed in a similar 
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pattern as the activation of e-IF2α. 3-AP-Me induced Calnexin upregulation only in HCT-116 cells. 
Interestingly, after 24 h no or only slight upregulation of the key ER chaperon GRP78 was observed for 
both compounds, whereas thapsigargin treatment showed a clear induction of this upstream initiator of 
UPR signaling (Supplemental Figure 1). Higher expression of GRP78 was first detectable after 48 h 3-AP 
or 3-AP-Me treatment in SW480 cells, with 3-AP-Me again being more active than 3-AP. However, no 
GRP78 upregulation was observed in HCT-116 cells. In both cell lines, a distinct upregulation of the pro-
apoptotic factor CHOP was determined after 24 h 3-AP-Me treatment, while CHOP upregulation in 3-
AP-treated cells was only observed at the highest concentration (25 µM).  
To address the effects of 3-AP and 3-AP-Me on the transcriptional level of UPR, expression levels of 
several key factors were quantified by RT-qPCR. Analysis of mRNA expression levels of CHOP and 
GRP78 confirmed the pro-apoptotic signaling of UPR. After 24 h treatment with 3-AP-Me CHOP mRNA 
level was found significantly higher in both cell lines (Fig. 3B). 3-AP-Me led to an up to 11-fold 
upregulation in SW480 cells, whereas 3-AP treatment led only to slightly elevated levels (2-fold). In 
HCT-116 cells, the highest CHOP expression was found with 25 µM 3-AP treatment. Nevertheless, 
CHOP overexpression was more pronounced at lower concentrations of 3-AP-Me. However, no 
significant upregulation of the pro-survival factor GRP78 was observed for both compounds, which is 
good accordance with the previous observations on the protein level. Together these results provide 
strong evidence that both compounds induce severe ER stress, and terminal dimethylation (3-AP-Me) 
strongly increases these effects compared to 3-AP. 
3-AP-Me activates transcriptional upregulation program of XBP1, ATF4 and ATF6. The 
transcription factors ATF4, ATF6, and X-box binding protein 1 (XBP-1) are downstream effectors of 
UPR signaling and play an essential role in CHOP induction (Oyadomari and Mori, 2004). Substantial ER 
stress promotes alternative splicing to the 26 bp shorter mRNA variant (141 bp), which results in a 
frameshift and encodes the bZip transcription factor XBP1s (Yoshida et al., 2001). Fluorescence-labeled 
probes were designed to quantify the mRNA of the full length XBP1u and the alternatively spliced 
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XBP1s via RT-qPCR in a duplex reaction. As shown in Figure 3C, 24 h treatment with 3-AP-Me resulted 
in an up to 16- and 14-fold upregulation of XBP1s in SW480 and HCT-116 cells, respectively. At the 
same time, a significant downregulation (~10-fold) of XBP1u in both cell lines was observed for 3-AP-
Me treatment. On the contrary, 3-AP-treated cells did not upregulate the alternatively spliced XBP1s at 
any used concentration. Rather, a slight downregulation of XBP1s mRNA was detected after 3-AP 
treatment. After 8 h no changes in XBP1 splicing was observed (Supplemental Figure 2). Moreover, the 
transmembrane receptor IRE1a mRNA was found overexpressed (up to 29-fold), and again 3-AP-Me 
induces a significantly enhanced expression at lower concentrations (Supplemental Figure 3). In good 
accordance with these findings, analysis of the transcription factors ATF4 and ATF6 displayed a 
significant upregulation of mRNA expression after 3-AP-Me treatment in SW480 cells. Surprisingly, in 
HCT-116 cells expression levels for ATF4 and ATF6 were only slightly elevated after 3-AP-Me 
treatment, whereas high concentrations of 3-AP (25 µM) lead to a significant upregulation of both 
transcription factors. Taken together, our findings show a distinct induction of UPR transcription factors 
XBP1, ATF4, and ATF6 for 3-AP-Me treated cells. Activation of the transcriptional upregulation 
program of IRE1a, ATF4, and ATF6 and the alternative XBP1 splicing demonstrate severe ER stress and 
a distinct activation of signaling branches of transmembrane receptors IRE1a and ATF-6.   
3-AP and 3-AP-Me induce ER stress in a ROS-independent way. ROS can play a critical role in ER 
stress induction, and generation of ROS via Fenton-like reactions was demonstrated for an iron-3-AP 
complex previously (Shao et al., 2006). To investigate the role of ROS in the anticancer activity of 3-AP 
and 3-AP-Me in SW480 cells, the radical scavenger N-acetyl cysteine (NAC) was used. Supplemental 
Figure 4A shows the H2O2 and hydroxyl radical generation after 30 min drug treatment, visualized by the 
ROS-sensitive dye DCF-DA (Gomes et al., 2005). For neither of the two drugs, a significant increase of 
intracellular ROS levels could be observed and, thus, NAC co-treatment had no effect in these 
experiments. Also in 72 h viability assays, co-treatment with NAC did not protect cells from 3-AP or 3-
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AP-Me cytotoxicity (Supplemental Figure 4B). Thus, in contrast to the literature, where intracellular ROS 
generation by the iron-3-AP complex is suggested, our data indicate no significant increase in ROS levels. 
3-AP and 3-AP-Me activate the p38 MAPK and JNK pathway and trigger Bim expression. Next, the 
effects of 3-AP and 3-AP-Me treatment on p38 MAPK and JNK activation were studied. It has been 
reported that the activation of JNK and p38 MAPK is associated with ER stress and ER stress-initiated 
cell death (Urano et al., 2000; Maytin et al., 2001; Luo and Lee, 2002). Western blot experiments showed 
phosphorylation of JNK and p38 MAPK after 12 h incubation with 3-AP or 3-AP-Me (Fig. 4A). 
Concentration dependency was only observed in the case of 3-AP because 3-AP-Me exerted a much 
stronger, near maximum effect already at the lowest concentration applied. A sharp decrease in 
phosphorylated levels of JNK and p38 MAPK at the highest tested concentration of 3-AP-Me (25 µM) in 
SW480 cells may indicate an already completed stress response. Furthermore, expression of the Bcl-2 
protein family member Bim was analyzed, as it is known to be triggered by severe ER stress. Distinct 
upregulation in a concentration-dependent manner was observed for 3-AP and 3-AP-Me in both cell lines 
(Fig. 4A). These results indicate a severe cellular stress response and induction of the proapoptotic BH3-
only member Bim, which is essential for ER-stress mediated apoptosis (Puthalakath et al., 2007).  
Reduced protein burden and inhibition of stress response diminish antiproliferative effects of 3-AP 
and 3-AP-Me. Subsequently, we investigated if reduced protein biosynthesis and inhibition of cellular 
stress response have an influence on the antiproliferative effect of 3-AP and 3-AP-Me. For this purpose, 
cycloheximide (CHX), a protein synthesis inhibitor which thereby reduces the protein load to the ER, and 
a ATP-competitive JNK inhibitor were used. Co-treatment with each inhibitor reduced the 
antiproliferative effect of both compounds significantly. The cytotoxicity of 3-AP decreased markedly to 
IC50 values of 15.8 µM (21-fold) or 6.5 µM (8.6-fold) with co-incubation of 10 µM JNK inhibitor or 
1.25 µM protein synthesis inhibitor CHX, respectively (Figure 4B). Although the reduction of 
antiproliferative properties of 3-AP-Me were less pronounced, the increase of IC50 values with JNK 
inhibitor and/or CHX was statistically significant (p < 0.001). The combination of the JNK inhibitor and 
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CHX together inhibited the activity of the thiosemicarbazones not more than each inhibitor alone. These 
results provide strong evidence that reduced protein load and/or inhibition of cellular stress kinases have a 
direct impact on the cytotoxic effects of 3-AP and 3-AP-Me.   
Dimethylation of 3-AP leads to enhanced depolarization of mitochondrial membranes. Changes in 
mitochondrial membrane potential (ΔΨm) are key events in apoptosis induction, and recent studies 
showed that non-resolved ER stress leads to mitochondrial membrane permeabilization and loss of ΔΨm 
(Gupta, Cuffe, et al., 2010). To monitor ΔΨm, flow cytometric analysis with the fluorescence dye JC-1 
was used in human HL-60 leukemia cells after 24 h treatment with different concentrations (0.25-0.1 µM) 
of 3-AP or 3-AP-Me. As shown in the contour plots in Figure 5, HL-60 cells treated with 3-AP-Me 
showed a markedly enhanced depolarization of mitochondrial membranes compared to 3-AP. HL-60 cells 
displayed a loss of mitochondrial membrane potential of about 30% at a concentration of 0.25 µM of 3-
AP-Me. Concentrations of 0.5 and 1 µM resulted in up to 50% of cells with depolarized mitochondrial 
membranes. In contrast, 0.25 and 0.5 µM of 3-AP caused only a slight or no decrease in ΔΨm. However, 
3-AP treatment at 1 µM led to 40% cells with depolarized mitochondrial membranes. 
Discussion 
In this study, we revealed the subcellular co-localization of 3-AP and its terminal dimethylated derivative 
3-AP-Me, with organelle-specific fluorescent trackers, which indicated accumulation of the compounds in 
the ER and/or mitochondria. To investigate if the cellular site of accumulation is associated with the 
intracellular site of action, the influence of 3-AP and 3-AP-Me on ER functions, in particular the UPR, 
was studied for the first time. The UPR can be triggered by a wide variety of causes, including 
accumulation of misfolded/unfolded proteins, imbalances in ER lipids and glycolipids, changes in the 
redox environment of ER caused by ROS, and disruption of Ca2+ homeostasis. Recent studies showed that 
Cu2+ thiosemicarbazone complexes generate oxidative stress in cell-based assays, whereas the metal-free 
compounds do not (Hancock et al., 2011; Lovejoy et al., 2011; Kowol et al., 2012). Furthermore, the Cu2+ 
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complex of the thiosemicarbazone NSC 689534 was shown to induce ER stress in a ROS-dependent 
manner, whereas the metal-free NSC 689534 does neither induce oxidative nor ER stress (Hancock et al., 
2011). In contrast, our study revealed that the metal-free thiosemicarbazones 3-AP and 3-AP-Me induce 
ER stress in a ROS-independent manner. Furthermore, their cytotoxicity was not associated with 
oxidative stress. 
Activation of the UPR was proven by upregulation of several proteins including p-eIF2α, PERK, 
calreticulin and CHOP. The translation initiation factor eIF2α gets phosphorylated on Ser51 by PERK, a 
type I transmembrane protein and initiator of UPR (Schmitt et al., 2010). By phosphorylation of the α-
subunit of eIF2α the translation of most mRNAs is downregulated to reduce the burden on the stressed 
ER by decreasing the amount of newly synthesized polypeptides (Boyce and Yuan, 2006). On the other 
hand, p-eIF2α upregulates ATF4, which in turn stimulates the expression of ER chaperons such as GRP78 
to restore ER homeostasis (Harding et al., 2003). However, if the protein machinery is severely disturbed, 
the pro-survival signaling can switch to a pro-apoptotic pathway by upregulation of CHOP, whose 
induction strongly depends on ATF4 (Szegezdi et al., 2006). CHOP plays an essential role in ER stress-
mediated apoptosis by regulating genes involved in cell life and death decisions (Matsumoto et al., 1996). 
Western blot analysis displayed a strong upregulation of eIF2α phosphorylation after 3-AP-Me treatment, 
whereas for 3-AP only a slight increase was observed. Remarkably, upregulated CHOP levels were 
observed upon 3-AP or 3-AP-Me treatment, whereas no increased expression of GRP78 was observed. In 
order to overcome acute ER stress, chaperons such as GRP78 are upregulated by the UPR to increase ER 
folding capacity, and thus high levels of GRP78 are associated with pro-survival signaling of ER stress 
responses (Lee, 2007; Pyrko et al., 2007). We found increased protein expression of GRP78 only after 
48 h treatment in SW480 cells, but not in HCT-116 cells. These results were confirmed by mRNA 
expression analysis, which showed significantly upregulated levels of the pro-apoptotic factor CHOP and 
only little or no elevated mRNA levels of GRP78. Increased levels of CHOP without upregulation of 
GRP78 suggest a severely disturbed ER homoeostasis and indicate an imbalance of anti- and pro-
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apoptotic signals in favor of the latter (Suzuki et al., 2007). In contrast to 3-AP and 3-AP-Me, treatment 
with the ER stress inducer thapsigargin led to upregulation of GRP78 in all used cell lines. Furthermore, 
reducing the protein load by inhibiting protein synthesis led to a significant reduction of the 
antiproliferative properties of both compounds. Remarkably, the reduction of cytotoxicity by CHX co-
incubation was less pronounced for 3-AP-Me, which is a stronger inducer of ER stress. The distinctly 
higher induction of ER stress by 3-AP-Me compared to 3-AP supports the assumption that the 
dimethylamine moiety plays a crucial role in the induction of pro-apoptotic signaling of the UPR. 
During ER stress XBP1s regulates several UPR-related genes, such as p58IPK, CHOP, and XBP1 itself 
(Lee et al., 2003). Analysis of both XBP1 mRNA splicing variants by RT-qPCR showed a strong 
induction of the alternatively spliced variant XBP1s by 3-AP-Me treatment, while in the case of 3-AP no 
upregulation of XBP1s mRNA was observed. This emphasizes that the dimethylamine moiety is a crucial 
factor for induction of the IRE1a-XBP1 branch of the UPR. Furthermore, the IRE1a-TRAF2-ASK1 
pathway is thought to be coupled with cellular stress-activated protein kinases such as JNK and p38 
MAPK, which are assumed to play an important role in ER stress-mediated apoptosis (Urano et al., 2000; 
Luo and Lee, 2002; Gupta, Deepti, et al., 2010). In accordance with the increased UPR protein expression, 
both compounds led to elevated levels of phosphorylated p38 MAPK and JNK. After exposure to 3-AP or 
3-AP-Me, the activation of JNK and p38 MAPK signaling indicates severe cellular stress. Co-incubation 
with a JNK inhibitor led to a significant reduction of antiproliferative properties of both compounds.   
The close interplay of ER and mitochondria supports signaling between those two organelles for various 
cellular functions including regulation of ER chaperones, ATP synthesis, and ER stress-induced apoptosis 
(Gupta, Cuffe, et al., 2010). Recent studies showed that ER stress triggers a loss of mitochondrial 
membrane potential via multiple signals such as induction of BH3-only proteins (Gupta, Cuffe, et al., 
2010). Furthermore, is has been shown that elevated levels of CHOP result in upregulation of pro-
apoptotic bcl-2 family member Bim. (McCullough et al., 2001; Gotoh et al., 2004; Puthalakath et al., 
2007). In this study, we were able to demonstrate that treatment with 3-AP and 3-AP-Me leads to 
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upregulation of the pro-apoptotic protein Bim. These findings are in good agreement with increased levels 
of phosphorylated JNK, which is known for its regulatory functions on members of the bcl-2 protein 
family (Weston and Davis, 2007). Depolarization of mitochondrial membranes support the concept of ER 
stress-mediated apoptosis via induction of BH3-only proteins. In good accordance with this concept, it 
was shown that the enhanced ER stress induction by 3-AP-Me is associated with a more pronounced 
depolarization of mitochondrial membranes.  
In good accordance with our results, mRNA expression studies with the thiosemicarbazone Dp44mT (di-
2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone) suggested that iron depletion is responsible for 
elevated levels of DITT3 (a synonym for the gene encoding CHOP) (Yu and Richardson, 2011). Indeed, 
investigations regarding the stability of metal complexes of 3-AP and 3-AP-Me with iron, zinc, and 
copper revealed that terminally dimethylated thiosemicarbazones such as 3-AP-Me form metal complexes 
with higher stability (Enyedy et al., 2010, 2011). Both compounds form iron complexes with fairly high 
stability. Stability of the complexes [FeII/III(L)2] (L = 3-AP or 3-AP-Me) can be compared by the overall 
stability constants (logβ([FeII/III(L)2]) –2×logβ(H2L), which are -6.85 and -5.04 for the FeII complexes and 
-2.80  and -0.33 for the FeIII species in the case of 3-AP and 3-AP-Me, respectively. The higher values 
represent the greater stabilities. The several orders of magnitude higher constants clearly reveal that 
dimethylation of the terminal nitrogen leads to more stable iron complexes (Enyedy et al., 2011).  Metal 
complexation characteristics of thiosemicarbazones might interfere with proper folding of metalloproteins, 
and the ability of 3-AP-Me to form metal complexes with higher stability may be responsible for the 
enhanced ER stress.  
Taken together, the severe disruption of the protein folding machinery may represent a new molecular 
target in addition to the ribonucleotide reductase inhibition potential of thiosemicarbazones. Our results 
indicate that ER stress and the induction of cellular stress kinases are an additional mechanism of the 
antitumor activity of the clinically investigated 3-AP, and can be distinctly increased by terminal 
dimethylation of the compound. 
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Figure Legends 
Figure 1. Chemical structures and absorption/emission spectra of 3-AP and 3-AP-Me. A) Structural 
formula of 3-AP and 3-AP-Me. B) UV/vis absorption spectrum of 3-AP (black solid line) and 3-AP-Me 
(grey solid line) (cL = 0.05 mM) and fluorescence emission spectrum of 3-AP (black dashed line) and 3-
AP-Me (gray dashed line) (cL = 0.01 mM; λEX = 360 nm), pH 7.4 in 30% (w/w) DMSO/H2O, t = 25.0 °C, 
I = 0.10 M (KCl).   
Figure 2. Live cell fluorescence microscopy images of SW480 colon carcinoma cells. Cells were co-
stained in a stepwise procedure in a flow cell with 100 µM (A) 3-AP or (B) 3-AP-Me and ER-Tracker 
Green (1 µM) or Mito-Tracker Red (200 nM) for 5 min each. After each staining step, cells were washed 
three times with PBS. Insert depicts higher magnification. Scale bar is 20 µm.  
Figure 3. 3-AP and 3-AP-Me induces key factors of the unfolded protein response. (A) Western blot 
analysis of PERK, eIF2α phosphorylation, calreticulin, calnexin, CHOP and GRP78 were analyzed in 
SW480 and HCT-116 colon carcinoma cells after 3-AP or 3-AP-Me treatment. 0.5 µM Thapsigargin (Tha) 
was used a positive control. Shown results are representatives out of three independent experiments. (B) 
Change in gene expression of CHOP and GRP78 mRNA measured by RT-qPCR in SW480 and HCT-116 
cells were treated for 24 h at the indicated concentrations. (C) Change in gene expression of splicing 
variants of XBP1 mRNA and activation of the transcription factors ATF4 and ATF6 measured by RT-
qPCR. SW480 or HCT-116 cells were treated with indicated concentration of 3-AP or 3-AP-Me for 24 h. 
Bars display means ± S.D. of three independent experiments (n=6); *p < 0.05;**p < 0.01; ***p < 0.001, 
compared with control, as calculated by a one-way ANOVA test. 
 
Figure 4. 3-AP and 3-AP-Me activate the cellular stress kinases p38 MAPK and JNK and trigger Bim 
expression. (A) Western blot analysis of JNK and p38 MAPK phosphorylation in SW480 and HCT-116 
cells after 12 h treatment. Expression of the three Bim isoforms (BimEL, BimL and BimS) was analyzed by 
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Western blot after 24 h. Cells were treated with 1, 5, 25 or 50 µM of 3-AP or 3-AP-Me. Results shown 
are representatives out of three independent experiments. (B) Cytotoxic effects of 3-AP or 3-AP-Me were 
analyzed with co-incubation of 1.25 µM cycloheximide (CHX) and 10 µM JNK inhibitor SP600125 in 
HCT-116 cells after 72 h by the MTT assay. IC50 values and % survival are displayed for 6 independent 
experiments (n=6). Columns display means ± S.D. *p < 0.05;**p < 0.01; ***p < 0.001, compared with 3-
AP or 3-AP-Me alone, as calculated by a one-way ANOVA test. 
 
Figure 5. Depolarization of mitochondrial membranes by 3-AP and 3-AP-Me, detected by flow 
cytometric analysis upon JC-1 staining. JC-1 forms aggregates (orange fluorescence) under normal 
membrane potential, while in depolarized mitochondrial membranes JC-1 dissociates to monomers (green 
fluorescence). HL-60 leukemia cells were treated with 0.25, 0.5 or 1 µM 3-AP or 3-AP-Me for 24 h. 
Results shown are representatives out of three independent experiments.  
 
 
 





